ClearPoint Neuro, Inc. (CLPT)

Market Cap	414.98M
Revenue (ttm)	34.33M
Net Income (ttm)	-23.14M
Shares Out	28.42M
EPS (ttm)	-0.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	408,786
Open	14.35
Previous Close	14.40
Day's Range	14.10 - 14.73
52-Week Range	9.76 - 30.10
Beta	0.98
Analysts	Strong Buy
Price Target	27.67 (+89.52%)
Earnings Date	Nov 6, 2025

About CLPT

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; li...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 115
• Stock Exchange: NASDAQ
• Ticker Symbol: CLPT
• Website: https://www.clearpointneuro.com

Financial Performance

In 2024, ClearPoint Neuro's revenue was $31.39 million, an increase of 31.04% compared to the previous year's $23.96 million. Losses were -$18.91 million, -14.37% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for CLPT stock is "Strong Buy." The 12-month stock price target is $27.67, which is an increase of 89.52% from the latest price.

Price Target

$27.67

(89.52% upside)

Analyst Consensus: Strong Buy